Archive

The remarkable growth of the Middle East and North Africa region’s (MENA) healthcare sector over the previous decade, fueled by both public and private finance, has firmly established…

Covid provided a big publicity opportunity for biotech. Investors of all kinds started taking interest in the companies that had the power to shorten the pandemic, and save millions of…

Health and biotech startups passed a combined $4T in value in 2021. With record VC investment raised, and more unicorns produced than in any previous 12-month period, we look back…

Psychedelic drugs to treat mental health disorders has been around for decades, but in 2020 this area received the focus of investors with added relevance as the current…

Digital therapeutics (DTx) are playing an increasingly central role in the future of healthcare, by delivering an evidence-based intervention via software or medical device to replace or complement disease treatment.

Despite a blockbuster 2020, health and biotech startups are continuing to smash all records in 2021. In partnership with Emerge GHI, and as Q3 has come to an end,…